European Medicines Agency (EMA) | News and press releases Follow EMA fast tracks review of a medicine for metastatic pancreatic cancer EMA’s human medicines committee (CHMP) has started a phased review of data on daraxonrasib, a medicine intended for the treatment of metastatic pancreatic cancer. A phased… https://www.ema.europa.eu/en/news/ema-fast-tracks-review-medicine-metastatic-pancreatic-cancer ema.europa.eu
